Pentamidine isethionate

CAS No. 140-64-7

Pentamidine isethionate( Pentamidine Isethionate | Pentamidine isethionate salt | Pentamidine diisethionate )

Catalog No. M11706 CAS No. 140-64-7

Pentamidine isethionate is an antimicrobial agent for prevention and treatment of Pneumocystis pneumonia (PCP) caused by Pneumocystis jirovecii.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 30 In Stock
200MG 35 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Pentamidine isethionate
  • Note
    Research use only, not for human use.
  • Brief Description
    Pentamidine isethionate is an antimicrobial agent for prevention and treatment of Pneumocystis pneumonia (PCP) caused by Pneumocystis jirovecii.
  • Description
    Pentamidine isethionate is an antimicrobial agent for prevention and treatment of Pneumocystis pneumonia (PCP) caused by Pneumocystis jirovecii.(In Vitro):Pentamidine (0-10 μg/mL; 6 days; WM9, DU145, C4-2, Hey, WM480, and A549 cells) treatment inhibits the growth of cancer cells in a concentration-dependent manner.The cytotoxic properties of Pentamidine isethionate towards the promastigotes of the protozoan parasite Leishmania infantum is determined. The leishmanicidal activity of Pentamidine isethionate is 60 times higher after 72 h of incubation than that of Cisplatin. Pentamidine isethionate induces a higher amount of programmed cell death (PCD) than Cisplatin, which is associated with inhibition of DNA synthesis and cell-cycle arrest in the G2/M phase. Binding of Pentamidine isethionate to calf-thymus DNA (CT-DNA) induces conformational changes in the DNA double helix, consistent with a B-->A transition. The interaction of Pentamidine isethionate with ubiquitin leads to a 6% increase in the beta-sheet content of the protein.(In Vivo):Pentamidine (0.25 mg/mouse; intramuscular injection; every 2 days; for 4 weeks; athymic nude mice) treatment markedly inhibits the growth of WM9 human melanoma tumors in nude mice.
  • In Vitro
    Cell Viability AssayCell Line:WM9, DU145, C4-2, Hey, WM480, and A549 cells Concentration:0-10 μg/mL Incubation Time:6 days Result:The growth of all six of the cell lines in culture was inhibited in a concentration-dependent manner with complete growth inhibition of the cell lines occurring at 10 μg/mL.
  • In Vivo
    Animal Model:Athymic nude mice (6 weeks old) injected with WM9 cellsDosage:0.25 mg/mouse Administration:Intramuscular injection; every 2 days; for 4 weeks Result:Markedly inhibited the growth of WM9 human melanoma tumors in nude mice.
  • Synonyms
    Pentamidine Isethionate | Pentamidine isethionate salt | Pentamidine diisethionate
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    140-64-7
  • Formula Weight
    592.68
  • Molecular Formula
    C23H36N4O10S2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 100mg/ml(168.73 mM);Water: 100mg/ml(168.73 mM);Ethanol: <1mg/ml
  • SMILES
    C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N.C(CS(=O)(=O)O)O.C(CS(=O)(=O)O)O
  • Chemical Name
    4,4'-(Pentamethylenedioxy)-dibenzamidine bis(2-hydroxyethanesulfonate)4-[5-(4-carbamimidoylphenoxy)pentoxy]benzenecarboximidamide;2-hydroxyethanesulfonic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Goa KL, Campoli-Richards DM. Drugs. 1987 Mar;33(3):242-58.
molnova catalog
related products
  • KU-2285

    KU-2285 shows anti-tumor, anti-metastatic and anti-colony forming effects on mouse melanoma B16.KU-2285 can be used to study pancreatic cancer.

  • DL-Alanine

    DL-Alanine is an amino acid that is a racemic compound of L- and D-alanine.DL-Alanine is often used as a reducing and capping agent in conjunction with aqueous silver nitrate for nanoparticle generation.DL-Alanine is a sweetening agent, and can be grouped with glycine and sodium saccharin.

  • Picroside IV

    Kutkoside is a mixture of iridoid glycosides namely, picroside II, Picroside IV and 6-ferulloylcatalpol, it may have antinociceptive and anti-inflammatory effects.